徕卡生物系统公司与Bio-Techne扩大合作，为BOND RX研究染色仪器上的自动化空间多组学实现无蛋白酶工作流程-动脉网

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

CISION 等信源发布 2025-04-02 19:00



可切换为仅中文







MINNEAPOLIS

明尼阿波利斯

，

April 2, 2025

2025年4月2日

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:

TECH

技术

) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology solutions. The expanded spatial multiomic collaboration now includes automation of ACD's new RNAscope™ Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument, further advancing the capabilities of spatial biology research..

）今天宣布其空间生物学品牌Advanced Cell Diagnostics（ACD）与解剖病理学解决方案的全球领导者Leica Biosystems之间长期合作关系的扩展。此次扩展的空间多组学合作现在包括在Leica的BOND RX研究染色仪器上自动化ACD的新RNAscope™多组学LS分析和无蛋白酶工作流程，进一步提升空间生物学研究的能力。

The RNAscope™ Multiomic LS Assay enables simultaneous fluorescent detection of up to six RNA and/or protein biomarkers on the same slide, preserving RNA and protein integrity while maintaining tissue morphology. Additionally, ACD introduced a protease-free workflow for RNAscope™ 2.5 single-plex assays on the Leica BOND RX staining instrument, further advancing multiomic visualization from discovery research to translational applications..

RNAscope™多组学LS检测试剂盒能够在同一张玻片上同时进行多达六种RNA和/或蛋白质生物标志物的荧光检测，在保持组织形态的同时保护RNA和蛋白质的完整性。此外，ACD推出了适用于Leica BOND RX染色仪的无蛋白酶RNAscope™ 2.5单重检测试剂工作流程，进一步推动了多组学可视化从发现研究到转化应用的进展。

'The automation of Bio-Techne's innovative RNAscope™ protease-free assays on the Leica BOND RX platform marks a significant milestone in spatial multiomics research,' said Dr. Matt McManus, President of Bio-Techne's Diagnostics & Spatial Biology Segment. 'High-precision visualization of RNA and protein biomarkers on the same slide empowers researchers with a streamlined, fully automated solution that preserves sample integrity and accelerates scientific discoveries in translational and clinical research.'.

“Bio-Techne 创新的 RNAscope™ 无蛋白酶检测在 Leica BOND RX 平台上的自动化标志着空间多组学研究的一个重要里程碑，”Bio-Techne 诊断与空间生物学部门总裁 Matt McManus 博士表示。“在同一张玻片上对 RNA 和蛋白质生物标志物进行高精度可视化，为研究人员提供了一种简化的、全自动的解决方案，该方案能够保持样本完整性，并加速转化和临床研究中的科学发现。”

The RNAscope™ in situ spatial assays have been widely adopted by top academic institutions, pharmaceutical companies, and service providers worldwide, contributing to over 12,000 peer-reviewed publications. This expansion builds on the strong partnership between Bio-Techne and Leica Biosystems, established in 2015, to deliver automated .

RNAscope™ 原位空间分析法已被全球顶尖学术机构、制药公司和服务提供商广泛采用，促成了超过12,000篇同行评审的出版物。这一扩展建立在Bio-Techne与Leica Biosystems于2015年建立的强大合作伙伴关系基础上，以实现自动化。

in-situ

原位

hybridization (ISH) workflows that streamline spatial biology research.

杂交 (ISH) 工作流程，可简化空间生物学研究。

'At Leica Biosystems, we are committed to empowering researchers with innovative automation solutions that accelerate spatial biology discovery,' said

“在徕卡生物系统公司，我们致力于为研究人员提供创新的自动化解决方案，以加速空间生物学的发现，”

Karan Arora

卡兰·阿罗拉

, Senior Vice President of Advanced Assays at Leica Biosystems. 'The integration of ACD's RNAscope™ Multiomic LS Assay on the BOND RX reinforces our mission to provide cutting-edge tools that enhance precision and scalability in life science research.'

徕卡生物系统公司高级副总裁。 “在BOND RX上集成ACD的RNAscope™多组学LS检测方法，进一步巩固了我们提供尖端工具的使命，这些工具可提高生命科学研究中的精确性和可扩展性。”

To learn more about Bio-Techne's

要了解更多关于Bio-Techne的信息，请访问

in-situ

原位

spatial assays automated on the BOND RX research staining instrument, visit:

访问BOND RX研究染色仪器上自动进行的空间分析：

https://www.leicabiosystems.com/us/life-sciences-and-research-solutions/partners/acd/

For Research Use Only. Not For Use In Diagnostic Procedures.

仅用于研究。不得用于诊断程序。

About Bio-Techne

关于Bio-Techne

Bio-Techne Corporation (NASDAQ:

生物技术公司（纳斯达克：

TECH

技术

) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.

）是一家全球生命科学公司，为科研和临床诊断界提供创新工具和生物活性试剂。Bio-Techne 产品助力对生物过程以及特定疾病的性质和进展的科学研究。它们辅助药物发现工作，并提供准确的临床测试和诊断手段。

With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately .

由于其产品组合中有数十万种产品，Bio-Techne 的年收入大约为。

$1.2 billion

12亿美元

in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit

在2024财年净销售额达到，并在全球拥有约3100名员工。有关Bio-Techne及其品牌的更多信息，请访问

http://www.bio-techne.com

or follow the Company on social media at

或在社交媒体上关注公司

Facebook

脸书

，

领英

，

Twitter

或

YouTube

。

About Bio-Techne Corporation

关于Bio-Techne公司

(NASDAQ:

（纳斯达克：

TECH

技术

)

Contact: David Clair, Vice President, Investor Relations & Corporate Development

联系人：大卫·克莱尔，副总裁，投资者关系与企业发展部

david.clair@bio-techne.com

612-656-4416

About Leica Biosystems

关于徕卡生物系统

Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology.

Leica Biosystems是一家癌症诊断公司，也是工作流程解决方案的全球领导者。只有Leica Biosystems提供涵盖从活检到诊断整个工作流程的最全面产品组合。凭借独特的专业知识，我们致力于推动跨放射学、病理学、外科和肿瘤学的创新连接。

Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of 'Advancing Cancer Diagnostics, Improving Lives' is at the heart of our corporate culture. Leica Biosystems is headquartered in .

我们的专家致力于提供更高质量、综合解决方案和优化效率，从而在诊断信心方面取得突破性进展。我们“推进癌症诊断，改善生活”的使命是我们企业文化的核心。徕卡生物系统公司总部位于。

Germany

德国

and operates in over 100 countries.

并且在超过100个国家开展业务。

SOURCE Bio-Techne Corporation

来源：Bio-Techne Corporation

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+